Immunomedics, Inc., (NASDAQ: IMMU) and Royalty Pharma today announced that Immunomedics has agreed to sell tiered, sales-based royalty rights on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings Hot Corp. News Trading Halts

Immunomedics (IMMU) PT Raised to $20 at Cowen on IMMU-132 DealJanuary 8, 2018 3:50 PM Immunomedics (IMMU) to Resume Trading at 9:00 am ETJanuary 8, 2018 8:47 AM Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 MillionJanuary 8, 2018 8:30 AM